plerixafor accord
accord healthcare s.l.u. - plerixafor - multiple myeloma; hematopoietic stem cell transplantation - imunostimulante, - adult patientsplerixafor accord is indicated in combination with granulocyte-colony stimulating factor (g-csf) to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in adult patients with lymphoma or multiple myeloma whose cells mobilise poorly (see section 4. paediatric patients (1 to less than 18 years)plerixafor accord is indicated in combination with g-csf to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in children with lymphoma or solid malignant tumours, either:- pre-emptively, when circulating stem cell count on the predicted day of collection after adequate mobilization with g-csf (with or without chemotherapy) is expected to be insufficient with regards to desired hematopoietic stem cells yield, or- who previously failed to collect sufficient haematopoietic stem cells (see section 4.
pedmarqsi
fennec pharmaceuticals (eu) limited - sodium thiosulfate - ear diseases; ototoxicity - toate celelalte produse terapeutice - pedmarqsi is indicated for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to < 18 years of age with localised, non-metastatic, solid tumours.
ciprofloxacin - rnp capsule 250 mg
rnp pharmaceuticals srl, im - ciprofloxacinum - capsule - 250 mg
ciprofloxacin - rnp capsule 500 mg
rnp pharmaceuticals srl, im - ciprofloxacinum - capsule - 500 mg
adenoprosin supozitoare 150 mg
biotehnos sa - adenoprosinum - supozitoare - 150 mg
clometryl ovule
farmaprim srl - combinaţie - ovule
adep 30 mg comprimate filmate
welfar healthcare limited - mirtazapinum - comprimate filmate - 30 mg
clometryl forte ovule
farmaprim srl - combinaţie - ovule